In terms of clinical implications, in one patient with previously known NSCLC and EGFR mutation, plasma and GSF-s allowed for the detection of an EGFR exon 20 p.T790M resistance mutation, despite the absence of tumor cells on pathologic examination. The gene discussed is EGFR; the disease is neoplasm.